Dr.Tobias Arkenau's second opinion

Tobias Arkenau

United Kingdom, 24 years of experience

Oncology

Area of expertise

Specialty

Oncology

Subspecialty

Medical Oncology

Diseases

Skin Cancers, Pancreatic Cancer, Gastric Cancer, Biliary Tract Cancer, Liver Cancer, Bowel Cancer, Small Bowel Cancer, Gastrointestinal Cancers

Procedures Performed

Immunotherapy

Chemotherapy

Targeted Therapy

Experience

CMO and Global Head of Drug Development, Ellipses Pharma

London, United Kingdom. From 2022

Clinical Lead, Oncology Service Line, HCA International

London, United Kingdom. 2015 - 2022

Professor, University College London

London, United Kingdom. 2011 - 2022

Executive Medical Director, Sarah Cannon Research Institute

London, United Kingdom. 2010 - 2022

Team Leader, Clinical Drug Development, University of New South Wales

Kensington, Australia. 2008 - 2010

Education

MD: Martin Luther University Halle-Wittenberg, Hannover Medical School

2000

Biography

Dr. Tobias Arkenau is a world-renowned expert in the clinical and translational development of new cancer treatments. He has over 20 years of experience and has worked on more than 300 oncology trials at all stages of development. Dr. Arkenau has a broad range of experience in treating patients with gastrointestinal cancers (bowel, stomach, pancreas, biliary tree, liver) and skin cancers using various treatments, such as immunotherapy, targeted therapy, and chemotherapies. Dr. Arkenau's caree

Affiliations

German Cancer Society

American Society of Clinical Oncology

American Association for Cancer Research

European Society for Medical Oncology

Publications

Dr. Tobias Arkenau has more than 200 publications

You’re only one click away from a life-changing journey

Virtual health assistant powered by AI
350+ world-renowned Doctors

© 2024 Docus. All rights reserved.